|
RNF160 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.175200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.408100E-04 |
| Normal-vs-Stage2 |
2.538400E-01 |
| Normal-vs-Stage3 |
1.816350E-01 |
| Normal-vs-Stage4 |
2.640600E-01 |
| Stage1-vs-Stage2 |
5.258000E-01 |
| Stage1-vs-Stage3 |
4.671800E-01 |
| Stage1-vs-Stage4 |
8.363400E-01 |
| Stage2-vs-Stage3 |
9.997600E-01 |
| Stage2-vs-Stage4 |
8.290400E-01 |
| Stage3-vs-Stage4 |
8.189600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.388300E-04 |
| Normal-vs-AfricanAmerican |
4.518500E-02 |
| Normal-vs-Asian |
3.159700E-02 |
| Caucasian-vs-AfricanAmerican |
5.576000E-01 |
| Caucasian-vs-Asian |
8.142200E-01 |
| AfricanAmerican-vs-Asian |
6.913800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.32129999999864E-05 |
| Normal-vs-Female |
5.786200E-01 |
| Male-vs-Female |
1.505590E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.464250E-02 |
| Normal-vs-Extreme_Weight |
3.38609999994688E-06 |
| Normal-vs-Obese |
1.739630E-01 |
| Normal-vs-Extreme_Obese |
1.687990E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.818400E-01 |
| Normal_Weight-vs-Obese |
3.213600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.155600E-01 |
| Extreme_Weight-vs-Obese |
1.851740E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.106000E-01 |
| Obese-vs-Extreme_Obese |
5.029800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.483200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.722000E-02 |
| Normal-vs-Age(61-80Yrs) |
6.35959999999436E-05 |
| Normal-vs-Age(81-100Yrs) |
1.73980000000018E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.216400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.139500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.087500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.468200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.276200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.457900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.189600E-04 |
| Normal-VS-Type2 PRCC |
1.260010E-03 |
| Normal-VS-KIRP CIMP |
8.782800E-01 |
| Normal-VS-Unclassified PRCC |
4.671800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.156600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.306960E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.436010E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.143570E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.267030E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.010600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.022400E-04 |
| Normal-vs-N1 |
8.098800E-01 |
| Normal-vs-N2 |
3.230000E-01 |
| N0-vs-N1 |
9.489800E-02 |
| N0-vs-N2 |
7.479200E-01 |
| N1-vs-N2 |
3.502200E-01 |
|
|
